Congress reconvenes in September for its last push to legislate before the November elections. – Liver Health Policy Update
Congress is entering a very busy work period in September, the last before the November elections. GLI is preparing for its Advanced Advocacy Academy (A3) and subsequent day on Capitol Hill to advocate for legislation!
Millennials and Generation X Face Higher Risk of Liver Cancer Than Previous Generations – Liver Cancer News
Thank you for being a part of Liver Cancer News! As we gear up for Liver Cancer Awareness Month next month, we are thrilled to announce the launch of a comprehensive patient toolkit designed to support our community throughout their cancer journey.
Let’s Ensure Access to Treatment for PBC Patients – Pediatric & Rare Liver Diseases News
With advancements in second-line treatments for PBC in 2024, both current and new treatment options must remain available, so that every patient can choose the treatment that best meets their needs.
New Guidelines & Actions for Change – Fatty Liver Disease News
New Clinical Practice Guidelines for MASLD, developed jointly by EASL, EASD, and EASO, update the 2016 guidelines to reflect recent advancements.
Global Liver Institute Welcomes Larry R. Holden as CEO
The Board of Directors of Global Liver Institute (GLI), the premier liver patient advocacy organization, has appointed Larry R. Holden as the organization’s Chief Executive Officer, as of September 2024.